Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huashi decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. It is specifically designed for the treatment of Polycystic Ovary Syndrome (PCOS), particularly in patients presenting with the "phlegm-dampness" syndrome according to TCM diagnostic criteria. The decoction is composed of multiple botanical ingredients that work synergistically to regulate the hypothalamic-pituitary-ovarian (HPO) axis, improve insulin sensitivity, and reduce hyperandrogenism. Clinical research conducted at the developing institution has demonstrated its potential to lower body mass index (BMI), reduce serum testosterone levels, and restore regular menstrual cycles and ovulation in women with PCOS. It is often used as an alternative or adjunct to conventional therapies like metformin or hormonal contraceptives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huashi decoction.